These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2316066)

  • 21. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
    Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
    Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated urine analysis in patients with calcium stone disease.
    Bek-Jensen H; Tiselius HG
    Eur Urol; 1998; 33(3):323-32. PubMed ID: 9555561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals.
    Berg C; Tiselius HG
    Urol Res; 1989; 17(3):167-72. PubMed ID: 2546314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of sodium-potassium citrate on the diurnal variations in urinary calcium oxalate and calcium phosphate saturation levels in normal individuals.
    Ogawa Y
    Br J Urol; 1994 Feb; 73(2):136-41. PubMed ID: 8131014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.
    Tardivel S; Médétognon J; Randoux C; Kébédé M; Drüeke T; Daudon M; Hennequin C; Lacour B
    Urol Res; 1999 Aug; 27(4):243-9. PubMed ID: 10460893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
    Sakhaee K; Nicar M; Hill K; Pak CY
    Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Res; 1985; 13(6):297-300. PubMed ID: 4095829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pH on the risk of calcium oxalate crystallization in urine.
    Berg C; Tiselius HG
    Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients.
    Herrmann U; Schwille PO; Schwarzlaender H; Berger I; Hoffmann G
    Urol Res; 1992; 20(5):347-53. PubMed ID: 1455567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Tiselius HG
    Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
    Bek-Jensen H; Tiselius HG
    Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine.
    Laube N; Schneider A; Hesse A
    Urol Res; 2000 Aug; 28(4):274-80. PubMed ID: 11011968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of crystallization risk formulas in pediatric calcium stone-formers.
    Sikora P; Zajaczkowska M; Hoppe B
    Pediatr Nephrol; 2009 Oct; 24(10):1997-2003. PubMed ID: 19333626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers.
    Sromicki J; Hess B
    Urolithiasis; 2020 Oct; 48(5):425-433. PubMed ID: 32524204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for disordered acid-base handling in calcium stone-forming patients.
    Worcester EM; Bergsland KJ; Gillen DL; Coe FL
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F363-F374. PubMed ID: 31790303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.